Drug intelligence / Profile preview

tocofersolan

Development stage
Phase 3
Lead developer
Recordati
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Tocofersolan is a synthetic, water-soluble derivative of vitamin E (α-tocopherol) created by conjugating it with polyethylene glycol succinate. Unlike natural forms of vitamin E, which are fat-soluble, tocofersolan’s amphipathic structure allows it to form micelles and be absorbed in the absence of bile salts. This property makes it effective for treating vitamin E deficiency in patients with fat malabsorption disorders such as congenital or hereditary chronic cholestasis. It is approved in the European Union under the brand name Vedrop for pediatric patients with these conditions. Tocofersolan also acts as an antioxidant and has applications as an excipient and absorption enhancer in pharmaceuticals and cosmetics[1][2][3][5]. Its mechanism involves halting lipid peroxidation by acting as a free radical scavenger, thereby protecting cell membranes from oxidative damage[2]. Additionally, it can inhibit P-glycoprotein (ABCB1) activity and tyrosine kinase activity according to some biochemical studies[6].

Brand names
Vedrop
Other names
tocophersolanD-alpha-tocopheryl polyethylene glycol 1000 succinatevitamin E TPGSvitamin E succinate
02

Targets

ABCB1 (P-glycoprotein)ABCA1 (ATP-binding cassette transporter A1)

Beyond the preview

Go deeper on tocofersolan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tocofersolan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call